Get informed when a big investor buys or sells
+ Follow535.71
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Foresee Pharmaceuticals , Ltd. posts a P/E ratio of 535.71. That is above the sector sector average of 24.62. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For its sector stocks, a P/E ratio near 24.62 is typical. Foresee Pharmaceuticals , Ltd.'s 535.71 is higher that level. That is roughly 2075.5% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Foresee Pharmaceuticals , Ltd.'s P/E ratio of 535.71 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.
Context for 6576.TWO's P/E ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 24.62), and (3) consistency with growth and profitability. This page covers the first two; Foresee Pharmaceuticals , Ltd.'s other metric pages and overview cover the third.